Thu, September 20, 2012
Wed, September 19, 2012
Tue, September 18, 2012
Mon, September 17, 2012
Sun, September 16, 2012
Fri, September 14, 2012
Thu, September 13, 2012
Wed, September 12, 2012
Tue, September 11, 2012
Mon, September 10, 2012
Sun, September 9, 2012
Fri, September 7, 2012
Thu, September 6, 2012
Wed, September 5, 2012
Tue, September 4, 2012

AxoGen to Present at Noble Financial Life Sciences Conference


//health-fitness.news-articles.net/content/2012/ .. at-noble-financial-life-sciences-conference.html
Published in Health and Fitness on Tuesday, September 11th 2012 at 9:51 GMT by Market Wire   Print publication without navigation


ALACHUA, Fla.--([ ])--AxoGen, Inc. (OTCBB: AXGN), a leader in the science and commercialization of surgical solutions for peripheral nerve repair, today announced that it will be presenting Monday, September 24, 2012 at the BioX a" Life Sciences Exposition sponsored by Noble Financial Capital Markets at the University of Connecticut, Stamford Campus. Gregory G. Freitag, AxoGenas Chief Financial Officer and Erick DeVinney, AxoGenas Director of Clinical and Translational Science, will participate in a panel discussion entitled aThe Explosion of a New Industry - Tissue Engineering & Biomaterialsa.

"It is pleasure to participate in this aspect of the regenerative medicine discussion"

aIt is pleasure to participate in this aspect of the regenerative medicine discussion,a said Erick DeVinney. aThe expansion of technology in the area of tissue engineering, including extracellular matrix scaffolds and cellular therapies, has continued and AxoGen is providing exciting new possibilities for treatment of peripheral nerve injuries. We are fortunate to be a leader in translating technology into impactful products that are used every day, and look forward to continuing to make advancements.a

Mr. Freitag will also give a Company presentation on AxoGen, Monday, September 24, 2012, at 3:30 PM Eastern Time. A live audio broadcast of Mr. Freitagas conference presentation will be available on the Companyas website, [ www.AxoGenInc.com ]. Following the live broadcast, a replay of the conference presentation will be available through the Company's website.

About AxoGen, Inc.

AxoGen (OTCBB: AXGN) is a regenerative medicine company dedicated to advancing the science of peripheral nerve repair and commercializing next generation surgical technologies. The Companyas portfolio of proprietary products and technologies offers new options for surgical nerve repair and reconstruction. AxoGenas products offer a full suite of surgical nerve repair solutions including Avance Nerve Graft, the only commercially available processed nerve allograft nerve for bridging nerve discontinuities of 5mm to 70mm in length, AxoGuard Nerve Connector, a coaptation aid allowing for close approximation of severed nerves, and AxoGuard Nerve Protector, a bioscaffold used to reinforce a coaptation site, wrap a partially severed nerve or isolate and protect nerve tissue. For more information, visit our website at [ www.AxoGenInc.com ]


Publication Contributing Sources